Sign in
Active, not recruitingNo phase

Supporting Treatment Access and Recovery Through Linkage and Support

Key facts

Who runs it
University of Massachusetts, Worcester
Where
Worcester, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
208 people, planned
Started
24 May 2023
Expected to end
Dec 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Full MISSION
  • Linkage Only Delivered by a Peer Specialist
Record updated
13 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Are 18 or older
  • Have a COD (1 or more substance use disorders (e.g., alcohol and illicit substances), and a mental health disorder (including depression, anxiety, trauma related disorders, bipolar, and/or schizophrenia)
  • Are in the Hub; and
  • Are not engaged in other ongoing multi-component treatment for COD with a behavioral health treatment provider or have not seen their provider for at least 3 months

Who cannot take part

  • Or with concurrent severe alcohol use disorder or high dose benzodiazepine requiring detoxification
  • We will exclude individuals who are acutely psychotic, acutely suicidal with a plan, or homicidal

Where in United States

  • University of Massachusetts Medical SchoolWorcester, United States

About the trial

What the trial wants to find out

This 3-year Hybrid Type 1 study will randomize 208 people with co-occurring substance use and mental health disorders (COD) referred from the Worcester Hub. This study seeks to evaluate the effectiveness of MISSION, a multi-component team approach, versus linkage with a Peer Specialist on improving outcomes among individuals with CODs. We expect that individuals receiving MISSION versus linkage only will show greater improvement in treatment engagement, substance use, and mental health outcomes. This study will also concurrently conduct a process evaluation to inform sustainability and future implementation of such interventions.

The 2 groups in the trial

  • Full MISSIONTreatment being tested

    Participants assigned to this condition will receive full MISSION services. MISSION services include 6-months of integrated mental health and substance use treatment and treatment planning with the MISSION Case Manager (13 session curriculum) and Peer Support Specialist (11 session curriculum). Content of these sessions will be directed using the MISSION Treatment Manual and Consumer Workbooks. MISSION teams will also provide linkages and supports to treatment services within the participant's community throughout the duration of the study.

  • Linkage Only Delivered by a Peer SpecialistExisting treatment, for comparison

    Our Linkage only arm delivered by a Peer Specialist will act as the comparison group to the MISSION arm. Participants randomized to the linkage only arm will receive 6-months of linkage care from a Peer Specialist. The Peer Specialist will provide informal treatment planning as well as linkages and support to community services, but will not provide integrated dual disorders treatment, nor will this arm utilize any MISSION materials or offer Peer led groups.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Rigorous Evaluation of Strategies to Prevent Overdose Through Linking People With Illicit Substance Use Disorder to Recovery Support Services
Record updated
13 October 2026